Approval · Notice of Compliance 20612 · 2018
VANECTYL-P: Notice of Compliance 20612
Issued March 13, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20612
- Date
- March 13, 2018
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of drug substance manufacturer site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANECTYL-P | 00170925 | Marketed |
Medicinal ingredients
- PREDNISOLONE 2 MG per TAB
- TRIMEPRAZINE TARTRATE 5 MG per TAB